Peter Sandys, Managing Partner of Seroba Life Sciences, invests in early- to mid-stage biotechnology and medtech companies across Ireland. See contact routes.
Peter Sandys, Managing Partner of Seroba Life Sciences, invests in early- to mid-stage biotechnology and medtech companies across Ireland, the U.K., Europe, and selectively in the U.S. His firm targets check sizes of approximately $5–7 million, with a sweet spot around $6 million, focusing on sectors including biotech, healthtech, medical devices, and pharmaceuticals. Notable portfolio companies include Endotronix (a later-stage VC investment of $45 million) and Sibylla Biotech (a Series A investment of $23 million). Seroba’s distinctive thesis centers on value creation by backing winning innovations that advance medical innovation and improve global health.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Dublin.
Investors like Peter Sandys · Full investor directory · Investor access · Company funding database